Venetoclax Add-On Improves Complete Remission in AML Venetoclax Add-On Improves Complete Remission in AML
A phase 2 study found 91% complete remission in patients with AML who received venetoclax plus standard therapy. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

No Improvement in CRC Outcomes With Vitamin E Supplementation No Improvement in CRC Outcomes With Vitamin E Supplementation
Adding a vitamin E analogue to standard therapy for metastatic colorectal cancer did not prolong time to first hospitalization or death. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Drug Combo May Prevent Chemo-Induced Neutropenia in Breast Cancer Drug Combo May Prevent Chemo-Induced Neutropenia in Breast Cancer
Plinabulin plus pegfilgrastim had more efficacy than pegfilgrastim alone in ameliorating chemotherapy-induced neutropenia. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Can Cancer Patients Get Approved COVID Therapies? Can Cancer Patients Get Approved COVID Therapies?
Although COVID-19 cases in the US have declined recently, demand for COVID-19 treatments continues to outstrip supply, leaving many oncologists with a difficult decision about who receives care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Study: Hospital Discharge Safe One Day Post-Brain Tumor Resection Study: Hospital Discharge Safe One Day Post-Brain Tumor Resection
A review of patients who underwent posterior fossa tumor resections found no significant increase in perioperative complication or 30-day readmission rates. The study has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Older Age for Menopause Raises Risk for Lung Cancer Older Age for Menopause Raises Risk for Lung Cancer
An analysis of more than 116,000 menopausal women showed those with a later age of natural menopause had a 35% increased rate of lung cancer but decreased risk for osteoporosis and fracture.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2022 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

High-risk HPV Infection Status Predicts Cervical Cancer Mortality High-risk HPV Infection Status Predicts Cervical Cancer Mortality
A significantly lower excess mortality was observed in high-risk HPV-positive vs high-risk HPV-negative patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

COVID and Cancer, Lessons Learned: AACR Call to Action COVID and Cancer, Lessons Learned: AACR Call to Action
It is important to learn from the lessons of this grave chapter in history to improve health equity, says a new report from the American Association for Cancer Research.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Panel Rejects Sintilimab Clinical Trial Data From China FDA Panel Rejects Sintilimab Clinical Trial Data From China
The new drug for lung cancer had clinical trial data only from China; FDA officials made clear their opposition to using studies conducted in only one nation as a basis for drug approvals.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breast Cancer Now Leading Cause of Cancer Death in Black Women Breast Cancer Now Leading Cause of Cancer Death in Black Women
Breast cancer has overtaken lung cancer as the leading cause of cancer death in Black women, although lung cancer remains the leading cause of cancer death in Black men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Gum Disease Linked to Colorectal Cancer: COLDENT Study Gum Disease Linked to Colorectal Cancer: COLDENT Study
Periodontal disease has previously been linked to cardiovascular, respiratory, chronic kidney, and metabolic diseases as well as Alzheimer ' s disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Biomarkers in Saliva May Detect Hepatocellular Carcinoma Biomarkers in Saliva May Detect Hepatocellular Carcinoma
MicroRNA biomarkers may provide a means of accurately and remotely testing for this increasingly common cancer, according to a small pilot study ' s results.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 10, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Confirmed: Cemiplimab Ups Survival in Recurrent Cervical Cancer Confirmed: Cemiplimab Ups Survival in Recurrent Cervical Cancer
Just published data from a phase 3 trial confirm that cemiplimab improves survival in patients with recurrent cervical cancer, as this indication awaits FDA approval.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 9, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Endometriosis Not Linked With Preterm Birth, New Study Finds Endometriosis Not Linked With Preterm Birth, New Study Finds
The results in a large study contradict those of some previous studies that have come to the opposite conclusion. An outside expert said this study likely should not be the final word on the subject.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 9, 2022 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health News Source Type: news

City of Hope Completes Acquisition of CTCA City of Hope Completes Acquisition of CTCA
City of Hope has now completed its acquisition of Cancer Treatment Centers of America (CTCA), making the combined group one of the largest cancer facilities in the US.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 9, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news